Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros

Banco de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Exp Cell Res ; 312(20): 3999-4010, 2006 Dec 10.
Artículo en Inglés | MEDLINE | ID: mdl-17014844

RESUMEN

The transcription factors MyoD and Myf5 present distinct patterns of expression during cell cycle progression and development. In contrast to the mitosis-specific disappearance of Myf5, which requires a D-box-like motif overlapping the basic domain, here we describe a stable and inactive mitotic form of MyoD phosphorylated on its serine 5 and serine 200 residues by cyclin B-cdc2. In mitosis, these modifications are required for releasing MyoD from condensed chromosomes and inhibiting its DNA-binding and transcriptional activation ability. Then, nuclear MyoD regains instability in the beginning of G1 phase due to rapid dephosphorylation events. Moreover, a non-phosphorylable MyoD S5A/S200A is not excluded from condensed chromatin and alters mitotic progression with apparent abnormalities. Thus, the drop of MyoD below a threshold level and its displacement from the mitotic chromatin could present another window in the cell cycle for resetting the myogenic transcriptional program and to maintain the myogenic determination of the proliferating cells.


Asunto(s)
División Celular , Fase G2 , Mitosis , Células Musculares/metabolismo , Proteína MioD/metabolismo , Animales , Proteína Quinasa CDC2/metabolismo , Línea Celular , Cromosomas/genética , Cromosomas/metabolismo , Ciclina B/metabolismo , Ratones , Proteína MioD/fisiología , Fosforilación , Complejo de la Endopetidasa Proteasomal/metabolismo , Serina/química , Transfección , Ubiquitina/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA